106 related articles for article (PubMed ID: 120679)
21. The familial nephrotic syndrome. II. A clinicopathological study.
Moncrieff MW; White RH; Glasgow EF; Winterborn MH; Cameron JS; Ogg CS
Clin Nephrol; 1973; 1(4):220-9. PubMed ID: 4206018
[No Abstract] [Full Text] [Related]
22. Should cyclosporine replace cytoxan or chlorambucil as the second-line drug for steroid-dependent nephrotic syndrome?
Brouhard BH
Semin Nephrol; 1998 May; 18(3):367-9. PubMed ID: 9613881
[No Abstract] [Full Text] [Related]
23. [Idiopathic membranous nephropathy].
Ponticelli C
Minerva Nefrol; 1983; 30(1):7-10. PubMed ID: 6341889
[No Abstract] [Full Text] [Related]
24. [Nephrotic syndrome in childhood].
Reusz G; Szabó A; Fekete A
Orv Hetil; 2006 Nov; 147(47):2251-60. PubMed ID: 17380687
[TBL] [Abstract][Full Text] [Related]
25. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
Bailey RR
N Z Med J; 1989 Jul; 102(872):379-81. PubMed ID: 2797556
[TBL] [Abstract][Full Text] [Related]
26. Mesangial IgM nephropathy.
Tejani A; Nicastri AD
Nephron; 1983; 35(1):1-5. PubMed ID: 6350912
[No Abstract] [Full Text] [Related]
27. Management of nephrotic syndrome.
Rath B
Indian Pediatr; 1997 Nov; 34(11):1003-12. PubMed ID: 9567530
[No Abstract] [Full Text] [Related]
28. [The use of chlorambucil in the nephrotic syndrome (NS) with frequent recurrences in children].
Ciardi MR; Ginevri F; Perfumo F; Gusmano R
Minerva Nefrol; 1979; 26(4):495-600. PubMed ID: 542219
[No Abstract] [Full Text] [Related]
29. [Membraneous-proliferating glomerulonephritis associated with the nephrotic syndrome].
Sarre H
Dtsch Med Wochenschr; 1971 Aug; 96(34):1373. PubMed ID: 4327320
[No Abstract] [Full Text] [Related]
30. Hereditary nephritis associated with nephrotic syndrome.
Karpouzas J; Psimenos G; Frimas C
Helv Paediatr Acta; 1974 Dec; 29(6):589-94. PubMed ID: 4457517
[No Abstract] [Full Text] [Related]
31. [Primary glomerulopathies--therapy using corticosteroids and cytostatics (immunosuppressive agents)].
Lagrue G; Bariéty J
Munch Med Wochenschr; 1970 Mar; 112(12):515-22. PubMed ID: 5467836
[No Abstract] [Full Text] [Related]
32. The advantages of immunosuppressive therapy in renal disease.
Zucchelli P
Ann Med Interne (Paris); 1988; 139(2):108-11. PubMed ID: 3293499
[TBL] [Abstract][Full Text] [Related]
33. [Cytostatic agents in treatment of the nephrotic syndrome].
Halvorsen S
Tidsskr Nor Laegeforen; 1971 Apr; 91(10):737. PubMed ID: 5577392
[No Abstract] [Full Text] [Related]
34. Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.
Drummond KN; Hillman DA; Marchessault JH; Feldman W
Can Med Assoc J; 1968 Mar; 98(11):524-31. PubMed ID: 5643296
[No Abstract] [Full Text] [Related]
35. Steroid-resistant idiopathic nephrotic syndrome. Results of azathioprine treatment in adults.
Teehan BP; Argy WP; Schreiner GE
Arch Intern Med; 1972 Dec; 130(6):877-82. PubMed ID: 5082468
[No Abstract] [Full Text] [Related]
36. Therapeutic trials in renal disease.
Black DA
Anglo Ger Med Rev; 1972 Mar; 6(3):97-101. PubMed ID: 4570438
[No Abstract] [Full Text] [Related]
37. Nephrotic syndrome.
Rahman M; Nazrul Islam KM; Hassan S
Bangladesh Med Res Counc Bull; 1977 Dec; 3(2):77-86. PubMed ID: 615592
[TBL] [Abstract][Full Text] [Related]
38. [Results of immunosuppressive treatment of nephrotic syndrome].
Przybyl L; Salwa-Kubasik W; Urbański K; Wróz M; Hryniewiecki J
Pol Tyg Lek; 1973 Jun; 28(26):990-3. PubMed ID: 4727614
[No Abstract] [Full Text] [Related]
39. [Prognosis of the idiopathic nephrotic syndrome in children].
Hooft C; van Acker KJ
Verh K Vlaam Acad Geneeskd Belg; 1974; 36(2):74-105. PubMed ID: 4365634
[No Abstract] [Full Text] [Related]
40. [Primary nephrotic syndromes in children in Iran].
Bodaghi E; Chamsa AM
Ann Pediatr (Paris); 1978 Jan; 25(1):61-70. PubMed ID: 16114307
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
